Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Skin Cancer01:30

Skin Cancer

Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Dermatology battles COVID-19 with comfort.

Cutis·2021
Same author

Diffuse Thick Scale on Both Hands.

American family physician·2018
Same author

Fractionated COâ‚‚Laser-Assisted Delivery of Topical 5-Fluorouracil as a Useful Modality for Treating Field Cutaneous Squamous Cell Carcinomas.

Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.]·2015
Same author

An ongoing series on dermatological issues of importance to the deployed special forces.

Journal of special operations medicine : a peer reviewed journal for SOF medical professionals·2013
Same author

Fractional thermoablation using an erbium-doped yttrium aluminum garnet fractionated laser for the treatment of pulsed dye laser-resistant port wine stain birthmarks.

Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.]·2011
Same author

Modification of the running suture to avoid wound edge protrusion.

Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.]·2011

Related Experiment Video

Updated: Jun 4, 2026

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells
06:09

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells

Published on: June 7, 2019

Managing melanoma in situ.

Kristen L Toren1, Eric C Parlette

  • 1Department of Dermatology, Walter Reed Army Medical Center, Washington, DC, USA.

Seminars in Cutaneous Medicine and Surgery
|February 1, 2011
PubMed
Summary
This summary is machine-generated.

Melanoma in situ, an early skin cancer, presents treatment challenges due to microscopic spread and cosmetic concerns. This review covers surgical and non-surgical options for difficult cases to prevent invasive melanoma.

More Related Videos

A 3D Organotypic Melanoma Spheroid Skin Model
08:49

A 3D Organotypic Melanoma Spheroid Skin Model

Published on: May 18, 2018

Minimally Invasive Isolated Limb Perfusion (MI-ILP) for Locally Advanced Melanomas and Sarcomas of the Extremity
09:38

Minimally Invasive Isolated Limb Perfusion (MI-ILP) for Locally Advanced Melanomas and Sarcomas of the Extremity

Published on: January 31, 2025

Related Experiment Videos

Last Updated: Jun 4, 2026

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells
06:09

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells

Published on: June 7, 2019

A 3D Organotypic Melanoma Spheroid Skin Model
08:49

A 3D Organotypic Melanoma Spheroid Skin Model

Published on: May 18, 2018

Minimally Invasive Isolated Limb Perfusion (MI-ILP) for Locally Advanced Melanomas and Sarcomas of the Extremity
09:38

Minimally Invasive Isolated Limb Perfusion (MI-ILP) for Locally Advanced Melanomas and Sarcomas of the Extremity

Published on: January 31, 2025

Area of Science:

  • Dermatology
  • Oncology
  • Surgical Oncology

Background:

  • Melanoma in situ (MIS) is a non-invasive form of aggressive skin cancer with rising incidence.
  • Treatment of MIS is complex due to subclinical spread and cosmetic concerns, especially on the head and neck.
  • Effective management is crucial to prevent progression to invasive melanoma and metastasis.

Purpose of the Study:

  • To review current surgical and non-surgical treatment strategies for melanoma in situ.
  • To address therapeutic dilemmas posed by MIS size, location, and microscopic spread.
  • To optimize tumor eradication while preserving cosmetic outcomes.

Main Methods:

  • Comprehensive literature review of surgical interventions for MIS.
  • Review of non-surgical management modalities for MIS.
  • Analysis of treatment outcomes and challenges in difficult MIS cases.

Main Results:

  • Multiple treatment regimens exist for MIS, each with specific indications and limitations.
  • Surgical excision remains a primary modality, with considerations for margin control and cosmetic preservation.
  • Non-surgical options are emerging for select cases, offering alternatives to invasive procedures.

Conclusions:

  • Optimal management of melanoma in situ requires careful consideration of tumor characteristics and patient factors.
  • Balancing complete tumor eradication with cosmetic results is paramount in treating MIS.
  • Further research into novel and refined treatment approaches for challenging MIS cases is warranted.